Inflammatory bowel disease: MR- and SPECT/CT-based macrophage imaging for monitoring and evaluating disease activity in experimental mouse model-pilot study

Radiology

Volumn 271, Issue 2, 2014, Pages 400-407

  Wu, Yingwei ^a,b   Briley Saebo, Karen ^c   Xie, Jingyuan ^a   Zhang, Ruihua ^c   Wang, Zhongqiu ^b   He, Cijiang ^c   Tang, Cheuk Ying ^c   Tao, Xiaofeng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; INDIUM 111; IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; THIOGLYCOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL FUNCTION; CELL LABELING; CELLULAR DISTRIBUTION; CLINICAL PROTOCOL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST TO NOISE RATIO; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ACTIVITY; EX VIVO STUDY; EXPERIMENTAL MOUSE; FEASIBILITY STUDY; HALF LIFE TIME; HISTOPATHOLOGY; IMAGING PHANTOM; IN VIVO STUDY; INFLAMMATORY BOWEL DISEASE; INTESTINE WALL; LIVER; MACROPHAGE; MASS SPECTROMETRY; MONITORING; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEUM MACROPHAGE; PILOT STUDY; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; CONTRAST MEDIA; DEXTRANS; DISEASE MODELS, ANIMAL; INDIUM RADIOISOTOPES; INFLAMMATORY BOWEL DISEASES; MACROPHAGES; MAGNESIUM CHLORIDE; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; MICE, INBRED C57BL; MULTIMODAL IMAGING; NANOPARTICLES; PHANTOMS, IMAGING; PILOT PROJECTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84899539550     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13122254     Document Type: Article

References (20)

1. Wang YF, Ouyang Q, Hu RW. Progression of inflammatory bowel disease in China. J Dig Dis 2010;11(2):76-82.
2. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002;31(1):1-20.
3. Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology 2007;133(5):1670-1689.
4. Rakoff-Nahoum S, Bousvaros A. Innate and adaptive immune connections in inflammatory bowel diseases. Curr Opin Gastroenterol 2010;26(6):572-577.
5. Blumberg RS. Inflammation in the intestinal tract: pathogenesis and treatment. Dig Dis 2009;27(4):455-464.
6. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361(21): 2066-2078.
7. Sohn JJ, Schetter AJ, Yfantis HG, et al. Macrophages, nitric oxide and micro RNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease. PLoS ONE 2012;7(9):e44156.
8. Cario E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis 2010;16(9):1583-1597.
9. Amirbekian V, Lipinski MJ, Briley-Saebo KC, et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci U S A 2007;104(3):961-966.
10. Trivedi RA, Mallawarachi C, U-King-Im JM, et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 2006;26(7):1601-1606.
11. Li D, Patel AR, Klibanov AL, et al. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ Cardiovasc Imaging 2010;3(4):464-472.
12. Khalil MM, Tremoleda JL, Bayomy TB, Gsell W. Molecular SPECT imaging: an overview. Int J Mol Imaging 2011;2011:796025.
13. Weinberg JB, Blinder RA, Coleman RE. In vitro function of indium-111 oxine-labeled human monocytes. J Immunol Methods 1986;95(1):9-14.
14. Pels Rijcken TH, Davis MA, Ros PR. Intraluminal contrast agents for MR imaging of the abdomen and pelvis. J Magn Reson Imaging 1994;4(3):291-300.
15. Small WC, DeSimone-Macchi D, Parker JR, et al. A multisite phase III study of the safety and efficacy of a new manganese chloridebased gastrointestinal contrast agent for MRI of the abdomen and pelvis. J Magn Reson Imaging 1999;10(1):15-24.
16. Briley-Saebo KC, Leboeuf M, Dickson S, et al. Longitudinal tracking of human dendritic cells in murine models using magnetic resonance imaging. Magn Reson Med 2010;64(5):1510-1519.
17. Ke YQ, Hu CC, Jiang XD, et al. In vivo magnetic resonance tracking of Feridex-labeled bone marrow-derived neural stem cells after autologous transplantation in rhesus monkey. J Neurosci Methods 2009;179(1):45-50.
18. Briley-Saebo KC, Johansson LO, Hustvedt SO, et al. Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism. Invest Radiol 2006;41(7):560-571.
19. Rad AM, Arbab AS, Iskander AS, Jiang Q, Soltanian-Zadeh H. Quantification of superparamagnetic iron oxide (SPIO)-labeled cells using MRI. J Magn Reson Imaging 2007;26(2):366-374.
20. Leander P, Golman K, Månsson S, Höglund P. Orally administered manganese with and without ascorbic acid as a liver-specific contrast agent and bowel marker for magnetic resonance imaging: phase I clinical trial assessing efficacy and safety. Invest Radiol 2010;45(9):559-564.